
From Theory to Practice: Hands-On RECIST Training at ECR 2026
This year, Mint Medical contributed to multiple program highlights at the ECR 2026 - bringing together innovation, education, and real-world clinical application.
GoTo
This year, Mint Medical contributed to multiple program highlights at the ECR 2026 - bringing together innovation, education, and real-world clinical application.
GoTo
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening program marks a significant step toward earlier…
GoTo
The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of advanced imaging technologies, and the need for…
GoTo
Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion and mdprostate. The collaboration connects…
GoTo
Early MRI scans are critical for patients who have just undergone brain tumor resection to evaluate the surgery's success and plan future treatments. However, the presence of intracranial air often…
GoTo
Postoperative MRI after brain tumor surgery is often affected by artifacts caused by intracranial air, limiting reliable image interpretation. A recent study shows that TGSE-BLADE DWI significantly…
GoTo
Requests for radiological clinical trial evaluations frequently rely on fragmented methods such as emails, phone calls, and spreadsheets. This decentralized approach often leads to communication…
GoTo
Establishing a Framework for Multicentric Data Coordination For many investigators, the transition from a single-site study to a multicentric model introduces significant logistical shifts in data…
GoTo
Following the FDA’s recent analysis of the growth rate constant (g) as a prognostic marker1, the challenge for many research organizations is implementation. mint Lesion provides a commercially…
GoTo
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always correlate perfectly with Overall Survival (OS) or…
GoTo